ESC: Semaglutide Beneficial for HFpEF Patients With Obesity

TUESDAY, Aug. 29, 2023 -- For patients with heart failure with preserved ejection fraction and obesity, semaglutide is associated with a larger reduction in symptoms and physical limitations, according to a study published online Aug. 25 in the New...